Related Experiment Video
Updated: May 26, 2026
Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
Chromatin remodeling-driven stratification and a five-gene RiskScore define proliferative aggressiveness and
Aiguo Zhu1,2, Xin Li1,2, Zhengchao Jin1,2
1Tianjin Cancer Hospital Airport Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Background:
Neuroblastoma is clinically heterogeneous, and epigenetic dysregulation-particularly chromatin remodeling-may organize aggressive tumor states and inform prognosis and therapeutic opportunities. This study aimed to define chromatin remodeling-associated neuroblastoma subtypes and develop a robust, biologically interpretable prognostic risk score derived from subtype-associated transcriptional changes, with external validation and functional characterization.
Methods:
A curated chromatin remodeling gene set was analyzed in RNA sequencing (RNA-seq) cohorts. Consensus clustering defined molecular subtypes in GSE62564 (n=498). Differential expression between subtypes [adjusted P value <0.05, |log fold change (FC)| ≥1] were screened by least absolute shrinkage and selection operator (LASSO) Cox regression. Collinearity control and multivariable Cox refinement yielded a five-gene signature. The RiskScore was evaluated by Kaplan-Meier analysis and time-dependent receiver operating characteristic (ROC) in GSE62564 and externally validated in GSE181559 (n=97) and FWR144 (n=144). Pathway analyses, transcription factor (TF) activity inference, and in silico drug sensitivity prediction were performed to support biological interpretation and therapeutic hypotheses.
Results:
Chromatin remodeling-based clustering stratified patients into prognostically distinct subtypes. The five-gene RiskScore robustly discriminated overall survival (OS) and achieved favorable time-dependent area under the curve (AUC) in the development cohort, remaining prognostic in both external cohorts. High-RiskScore tumors exhibited enhanced cell-cycle and DNA repair-related programs, consistent with a proliferative tumor-intrinsic aggressive phenotype. Drug sensitivity prediction suggested candidate vulnerabilities concordant with these mechanisms.
Conclusions:
Chromatin remodeling programs define reproducible neuroblastoma subtypes and support a stable five-gene prognostic RiskScore with external validation, linking aggressive biology to mechanistic pathways and therapeutic hypotheses.
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:23Abnormal Proliferation
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...